Clinical Research Directory
Browse clinical research sites, groups, and studies.
Deep Brain Stimulation for Spinocerebellar Ataxia
Sponsor: University of California, San Francisco
Summary
The goal of this clinical trial is to test the safety of placing Deep Brain Stimulators (DBS) in the cerebellum and using electrical stimulation of that part of the brain to treat symptoms related to the participants spinocerebellar ataxia. Five adults diagnosed with spinocerebellar ataxia type 6 (SCA6) with inadequate cerebellar symptom relief will be implanted with a Medtronic Percept Primary Cell Neurostimulator. The device will be implanted into the dentate nucleus, which is a structure located within the cerebellum that is responsible for controlling movement and balance. Specifically, the investigators will be using adaptive deep brain stimulation (aDBS), which analyzes brain signals and automatically adjusts the strength, timing, and pattern of stimulation according to the patient's needs at any given moment. This study will evaluate the feasibility, safety, and tolerability of aDBS in SCA6 patients.
Official title: Adaptive Deep Brain Stimulation Targeting the Dentate Nucleus to Treat Spinocerebellar Ataxia
Key Details
Gender
All
Age Range
21 Years - 89 Years
Study Type
INTERVENTIONAL
Enrollment
5
Start Date
2026-03
Completion Date
2031-03
Last Updated
2026-03-18
Healthy Volunteers
No
Interventions
Deep Brain Stimulation (DBS)
This device will be surgically implanted into the dentate nucleus of the cerebellum.
Locations (2)
UCSF Weill Institute for Neurosciences
San Francisco, California, United States
University of California, San Francisco
San Francisco, California, United States